Lumber producer Weyerhauser is set to benefit from President Trump's tariffs on Canada. The S&P 500 stock is up about 12% in 2025.

A court-appointed special master is recommending a 14-year-old whistleblower lawsuit not be allowed to move forward after ...

AbbVie will pay up to $2.2 billion to develop Danish drugmaker Gubra’s obesity drug. AI takes center stage at HIMSS conference gets underway in Vegas.

Clients should have three buckets of money for different time horizons and purposes and be diversified in assets, tax treatment, volatility, and risk, says Jill Williams, an Ameriprise private wealth ...

The tech-heavy Nasdaq Composite flirted with correction territory — defined as a drop of 10% from a recent high — on Tuesday, ...

If the Nifty 50 breaks 22,000 on a closing basis, selling pressure may drive the index down to 21,900-21,800. However, sustaining above 22,000 could propel the index toward 22,250-22,300 (which ...

Released on Jan. 3 under the moniker GELO — Ball also raps under the alias G3 —“Tweaker” came out on Ball’s family label, ...

The weekly derivative data suggested that the Nifty may see a trading range of 21,500-22,500 in the short term, with the ...

US stocks surged last year as strong economic growth, cooling inflation, a series of Federal Reserve rate cuts and enthusiasm for President-elect Donald Trump’s election victory boosted investor ...

Barclays raised the firm’s price target on Chart Industries (GTLS) to $165 from $145 and keeps an Equal Weight rating on the shares. Despite ...

ON24 is struggling with declining revenue and customer base. Click here to read why investors should approach ONTF stock with ...

The greater degree of control over integrating its equipment and processes also improved its pricing power, margins, and customer switching costs. Chart's 2025 expectations call for $4.75 billion in ...